Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients

• Jana Schmitt ,

  * E-mail: jana.schmitt@uniklinikum-saarland.de

  Affiliation Department of Human Genetics, Medical School, Saarland University, Homburg, Germany

  ⨯
• Andreas Keller,

  Affiliation Department of Human Genetics, Medical School, Saarland University, Homburg, Germany

  ⨯
• Nasenien Nourkami-Tutdibi,

  Affiliation Department of Paediatric Oncology and Haematology, Medical School, Saarland University, Homburg, Germany

  ⨯
• Sabrina Heisel,

  Affiliation Department of Human Genetics, Medical School, Saarland University, Homburg, Germany

  ⨯
• Nunja Habel,

  Affiliation Department of Human Genetics, Medical School, Saarland University, Homburg, Germany

  ⨯
• Petra Leidinger,

  Affiliation Department of Human Genetics, Medical School, Saarland University, Homburg, Germany

  ⨯
• Nicole Ludwig,

  Affiliation Department of Human Genetics, Medical School, Saarland University, Homburg, Germany

  ⨯
• Manfred Gessler,

  Affiliation Developmental Biochemistry, Biocenter, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Norbert Graf,

  Affiliation Department of Paediatric Oncology and Haematology, Medical School, Saarland University, Homburg, Germany

  ⨯
• Frank Berthold,

  Affiliation Department of Paediatric Oncology and Haematology, University of the Cologne, Cologne, Germany

  ⨯
• Hans-Peter Lenhof,

  Affiliation Center for Bioinformatics, Saarland University, Saarbruecken, Germany

  ⨯
• Eckart Meese

  Affiliation Department of Human Genetics, Medical School, Saarland University, Homburg, Germany

  ⨯